AAAAAA
Results: 201-225/568
Authors:
HODGE JW
Citation: Jw. Hodge, CARCINOEMBRYONIC ANTIGEN AS A TARGET FOR CANCER VACCINES, Cancer immunology and immunotherapy, 43(3), 1996, pp. 127-134
Authors:
TUTTLE TM
Citation: Tm. Tuttle, ONCOGENE PRODUCTS REPRESENT POTENTIAL TARGETS OF TUMOR VACCINES, Cancer immunology and immunotherapy, 43(3), 1996, pp. 135-141
Authors:
BARRATTBOYES SM
Citation: Sm. Barrattboyes, MAKING THE MOST OF MUCIN - A NOVEL TARGET FOR TUMOR-IMMUNOTHERAPY, Cancer immunology and immunotherapy, 43(3), 1996, pp. 142-151
Authors:
RAGUPATHI G
Citation: G. Ragupathi, CARBOHYDRATE ANTIGENS AS TARGETS FOR ACTIVE SPECIFIC IMMUNOTHERAPY, Cancer immunology and immunotherapy, 43(3), 1996, pp. 152-157
Authors:
SHURIN MR
Citation: Mr. Shurin, DENDRITIC CELLS PRESENTING TUMOR-ANTIGEN, Cancer immunology and immunotherapy, 43(3), 1996, pp. 158-164
Authors:
BASKAR S
Citation: S. Baskar, GENE-MODIFIED TUMOR-CELLS AS CELLULAR VACCINE, Cancer immunology and immunotherapy, 43(3), 1996, pp. 165-173
Authors:
SATO T
Citation: T. Sato, ACTIVE SPECIFIC IMMUNOTHERAPY WITH HAPTEN-MODIFIED AUTOLOGOUS MELANOMA CELL VACCINE, Cancer immunology and immunotherapy, 43(3), 1996, pp. 174-179
Authors:
DEBRUYNE L
Citation: L. Debruyne, TREATMENT OF MALIGNANCY BY DIRECT GENE-TRANSFER OF A FOREIGN MHC CLASS-I MOLECULE, Cancer immunology and immunotherapy, 43(3), 1996, pp. 180-189
Authors:
HAAS C
SCHIRRMACHER V
Citation: C. Haas et V. Schirrmacher, IMMUNOGENICITY INCREASE OF AUTOLOGOUS TUMOR-CELL VACCINES BY VIRUS-INFECTION AND ATTACHMENT OF BISPECIFIC ANTIBODIES, Cancer immunology and immunotherapy, 43(3), 1996, pp. 190-194
Authors:
HERLYN D
SOMASUNDARAM R
LI WP
MARUYAMA H
Citation: D. Herlyn et al., ANTIIDIOTYPE CANCER VACCINES - PAST AND FUTURE, Cancer immunology and immunotherapy, 43(2), 1996, pp. 65-76
Authors:
SATO T
MIDORIKAWA Y
YAMASHITA T
ARAKI A
SENDO F
Citation: T. Sato et al., THE NEUTROPHIL AS AN INFORMATION TRANSMITTER IN TUMOR-INHIBITION BY ASTREPTOCOCCAL BIOLOGICAL RESPONSE MODIFIER, OK-432, Cancer immunology and immunotherapy, 43(2), 1996, pp. 77-86
Authors:
HANAGIRI T
TAKENOYAMA M
YOSHIMATSU T
HIRASHIMA C
YOSHINO I
NAKANISHI K
NAGASHIMA A
NOMOTO K
YASUMOTO K
Citation: T. Hanagiri et al., EFFECTS OF INTERLEUKIN-12 ON IN-VITRO CULTURE WITH INTERLEUKIN-2 OF REGIONAL LYMPH-NODE LYMPHOCYTES FROM LUNG-CANCER PATIENTS, Cancer immunology and immunotherapy, 43(2), 1996, pp. 87-93
Authors:
TSAVARIS N
BAXEVANIS C
KOSMIDIS P
PAPAMICHAEL M
Citation: N. Tsavaris et al., THE PROGNOSTIC-SIGNIFICANCE OF IMMUNE CHANGES IN PATIENTS WITH RENAL-CANCER, MELANOMA AND COLORECTAL-CANCER, TREATED WITH INTERFERON-ALPHA-2B, Cancer immunology and immunotherapy, 43(2), 1996, pp. 94-102
Authors:
WEISS L
NUSAIR S
REICH S
SIDI H
SLAVIN S
Citation: L. Weiss et al., INDUCTION OF GRAFT-VERSUS-LEUKEMIA EFFECTS BY CELL-MEDIATED LYMPHOKINE-ACTIVATED IMMUNOTHERAPY AFTER SYNGENEIC BONE-MARROW TRANSPLANTATION IN MURINE B-CELL LEUKEMIA, Cancer immunology and immunotherapy, 43(2), 1996, pp. 103-108
Authors:
XIE KP
HUANG SY
WANG YF
BELTRAN PJ
JUANG SH
DONG ZY
REED JC
MCDONNELL TJ
MCCONKEY DJ
FIDLER IJ
Citation: Kp. Xie et al., BCL-2 PROTECTS CELLS FROM CYTOKINE-INDUCED NITRIC-OXIDE-DEPENDENT APOPTOSIS, Cancer immunology and immunotherapy, 43(2), 1996, pp. 109-115
Authors:
LAUSSON S
FOURNES B
BORREL C
MILHAUD G
TREILHOULAHILLE F
Citation: S. Lausson et al., IMMUNE-RESPONSE AGAINST MEDULLARY-THYROID CARCINOMA (MTC) INDUCED BY PARENTAL AND OR INTERLEUKIN-2-SECRETING MTC CELLS IN A RAT MODEL OF HUMAN FAMILIAL MEDULLARY-THYROID CARCINOMA/, Cancer immunology and immunotherapy, 43(2), 1996, pp. 116-123
Authors:
UOTILA P
Citation: P. Uotila, THE ROLE OF CYCLIC-AMP AND OXYGEN INTERMEDIATES IN THE INHIBITION OF CELLULAR-IMMUNITY IN CANCER, Cancer immunology and immunotherapy, 43(1), 1996, pp. 1-9
Authors:
MOURI T
NAKAMURA S
OHYAMA Y
MATSUZAKI G
SHINOHARA M
KISHIHARA K
HIROKI A
OKA M
SHIRASUNA K
NOMOTO K
Citation: T. Mouri et al., T-CELL RECEPTOR V-ALPHA AND V-BETA GENE USAGE BY TUMOR-INFILTRATING LYMPHOCYTES IN ORAL SQUAMOUS-CELL CARCINOMA, Cancer immunology and immunotherapy, 43(1), 1996, pp. 10-18
Authors:
CARDILLO M
YANKELEVICH B
MAZUMDER A
LUPU R
Citation: M. Cardillo et al., HEREGULIN INDUCES INCREASE IN SENSITIVITY OF AN ERBB-2-OVEREXPRESSINGBREAST-CANCER CELL-TYPE TO LYSIS BY LYMPHOKINE-ACTIVATED KILLER-CELLS, Cancer immunology and immunotherapy, 43(1), 1996, pp. 19-25
Authors:
ROSE LM
GUNASEKERA AH
DENARDO SJ
DENARDO GL
MEARES CF
Citation: Lm. Rose et al., LYMPHOMA SELECTIVE ANTIBODY LYM-1 RECOGNIZES A DISCONTINUOUS EPITOPE ON THE LIGHT-CHAIN OF HLA-DR10, Cancer immunology and immunotherapy, 43(1), 1996, pp. 26-30
Authors:
KUROSAWA S
HARADA M
SHINOMIYA Y
TERAO H
NOMOTO K
Citation: S. Kurosawa et al., THE CONCURRENT ADMINISTRATION OF OK432 AUGMENTS THE ANTITUMOR VACCINATION EFFECT WITH TUMOR-CELLS BY SUSTAINING LOCALLY INFILTRATING NATURAL-KILLER-CELLS, Cancer immunology and immunotherapy, 43(1), 1996, pp. 31-38
Authors:
ESSAND M
LOGDAHL P
NILSSON S
WARTENBERG M
ACKER H
CARLSSON J
Citation: M. Essand et al., RETENTION AND PROCESSING OF THE MONOCLONAL ANTI-PROSTATE E4 ANTIBODY AFTER BINDING TO PROSTATIC ADENOCARCINOMA DU-145 CELLS, Cancer immunology and immunotherapy, 43(1), 1996, pp. 39-43
Authors:
KRUL MRL
TIJHAAR EJ
KLEIJNE JAFW
VANLOON AM
NIEVERS MG
SCHIPPER H
GEERSE L
VANDERKOLK M
STEERENBERG PA
MOOI FR
DENOTTER W
Citation: Mrl. Krul et al., INDUCTION OF AN ANTIBODY-RESPONSE IN MICE AGAINST HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 AFTER IMMUNIZATION WITH HPV RECOMBINANT SALMONELLA STRAINS, Cancer immunology and immunotherapy, 43(1), 1996, pp. 44-48
Authors:
DEBRUYNE LA
CHANG AE
CAMERON MJ
YANG ZY
GORDON D
NABEL EG
NABEL GJ
BISHOP DK
Citation: La. Debruyne et al., DIRECT TRANSFER OF A FOREIGN MHC GENE INTO HUMAN-MELANOMA ALTERS T-CELL RECEPTOR V-BETA USAGE BY TUMOR-INFILTRATING LYMPHOCYTES, Cancer immunology and immunotherapy, 43(1), 1996, pp. 49-58
Authors:
SONI N
MEROPOL NJ
PORTER M
CALIGIURI MA
Citation: N. Soni et al., DIABETES-MELLITUS INDUCED BY LOW-DOSE INTERLEUKIN-2, Cancer immunology and immunotherapy, 43(1), 1996, pp. 59-62